ARCHIVES

NTP Board Approves Concept Of Human Cell Assay For Genetic Toxicity

This article is from The Cancer Letter archive.

Vol. 09 No. 12 | March 25, 1983

Download PDF Visit The Full Archive

Related Articles

Wallen Pleads Guilty To Lesser Charges, To Pay $20,000 to CALGB, FDA

August 31, 1984

Final Regulations For Clinical Cancer Education Program Adopted

October 3, 1975

FDA Approves BMS’s Yervoy For Metastatic Melanoma

March 25, 2011

Lenalidomide Found Effective For Lymphoma In Phase II Trial

December 26, 2008

“Treatment INDs” Seen As Major Threat To Clinical Trials

August 21, 1987

Docetaxel As Adjuvant Therapy Shows Benefit Over Standard

June 28, 2002